Quality by Design for Analytical Methods: Implications for Method Validation and Transfer - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Quality by Design for Analytical Methods: Implications for Method Validation and Transfer
The authors describe how traditional approaches to analytical method and validation may benefit from alignment with quality-by-design concepts.


Pharmaceutical Technology
Volume 36, Issue 10, pp. 74-79

References

1. P. Nethercote, et al., "QbD for Better Method Validation and Transfer," Pharmamanuf. online, http://www.pharmamanufacturing.com/articles/2010/060.html, accessed June 10, 2012.

2. FDA, Pharmaceutical cGMPs for the 21st Century—A Risk-Based Approach (Rockville, MD, 2004).

3. FDA, Guidance for Industry—Process Validation: General Principles and Practices (Rockville, MD, Jan. 2011).

4. M. Nasr, presentation at the AAPS Workshop (North Bethesda, MD, Oct. 5, 2005).

5. ICH, Q2(R1), Validation of Analytical Procedures: Text and Methodology, Step 4 version (2005).

6. P. Borman, et al., Pharm. Tech., 31 (10), 142–152 (2007).

7. USP General Chapter <1058>, "Analytical Instrument Qualification."

8. J. Ermer and J.S. Landy, "Validation of analytical procedures," in Encyclopedia of Pharmaceutical Technology, J. Swarbrick and J.C. Boylan, Eds. (Dekker, New York, 2nd ed., 2002), pp. 507–528.

9. ICH, Q8, Pharmaceutical Development (2009).

10. M. Schweitzer, et al., Pharm. Tech., 34(2), 52–59 (2010).

11. P.J. Borman, et al., Anal. Chim. Acta., 703(2), 101–113 (2011).

12. J. Ermer, et al., J. Pharm. Biomed. Anal., 38(4) 653–663 (2005).

13. USP General Chapter <1010>, "Analytical Data Interpretation & Treatment."

14. ICH, Q9, Quality Risk Management (2005).

15. ICH, Q10, Pharmaceutical Quality System (2008).

16. E. Ciurczak, "ICH Guidances (Already) Show Their Age," http://www.pharmamanufacturing.com/articles/2008/158.html, accessed June 10, 2012.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
Source: Pharmaceutical Technology,
Click here